Results 181 to 190 of about 16,686 (267)

CYLOSERINE AS AN ANTIDEPRESSANT AGENT

American Journal of Psychiatry, 1959
Cycloserine appears to be a psychopharmacological agent in that 1. It reverses depressions to normal or hyperactive mood and at the same time causes subtle changes in behavior; 2. It may aggravate mental disorders; and 3. It seems to potentiate Marsilid.
openaire   +2 more sources

Chapter 3 Antidepressant Agents

1987
Publisher Summary The major concerns in current anti-depression therapy are delayed onset of activity, less than ideal efficacy, the importance of proper patient selection, and biochemical predictors of treatment response and side effects. There are various obstacles.
Daniel Luttinger, Dennis J. Hlasta
openaire   +1 more source

Antidepressant-Antianxiety Agents

2012
The complex title of this chapter reflects several basic points about this important class of medicines. They are now the most widely used psychotropic drugs, and even more in general medicine than in psychiatry [171, 384, 576]. Their origins in the 1950s were aimed specifically at a relatively complex group of depressive disorders prior to ...
openaire   +1 more source

Chapter 3. Antidepressant Agents

1989
Publisher Summary This chapter discusses the several recent reviews that cover various aspects of depression and antidepressant research. The research on selective inhibitors of serotonin (5HT) uptake relative to their effects on the uptake of dopamine (DA) or norepinephrine (NE) has led to the successful development of selective serotonin reuptake ...
Jeffrey L. Ives, James Heym
openaire   +1 more source

Antidepressants II: tricyclic agents

2002
Abstract Tricyclic antidepressants (TCA) were first synthesized in the 1940s by chemists looking for drugs to act as sedatives, antihistamines, and anti-parkinsonian drugs (Baldessarini, 1996). Use in depression was first reported in the late 1950s, and hundreds of studies have confirmed their effectiveness in adult populations.
Karl Gundersen, Barbara Geller
openaire   +1 more source

Antidepressants III: other agents

2002
Abstract The low side effect profile, ease of use, and powerful clinical effect of the selective serotonin reuptake inhibitors (SSRIs) revolutionized the treatment of depression and anxiety in the 1990s. The success of the SSRIs shifted the focus from noradrenergic to serotonergic mechanisms in these common disorders. As we move into the
John T Walkup, Julia Ritter-Welzant, Elizabeth Kastelic, Nandita Joshi, Emily Frosch   +4 more
openaire   +1 more source

[Antidepressive agents in dementia].

Zeitschrift fur Gerontologie und Geriatrie, 2001
Antidepressants are used in demented patients for treating depressive symptoms as well as other non-cognitive symptoms including agitation, aggression and irritability. As patients are usually elderly, a dose adjustment is mandatory for all classes of antidepressants. New antidepressants such as the SSRIs and the reversible MAO inhibitors should be the
M, Korthals Altes, A, Kurz
openaire   +1 more source

[Antidepressive agents: benefits/risks].

L'Encephale, 1994
In 1994, the risk/benefit ratio when using antidepressant drugs for the treatment of mood disorders has become very difficult to assess. From the medical standpoint, frequent nosographical modifications generated new clinical entities (brief recurrent depression, subsyndromal depression, mixed anxiety and depression according to the ICD 10, dysthymia).
H, Cuche, A, Gérard
openaire   +1 more source

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

[ANTIDEPRESSIVE AGENTS].

[Sogo rinsho] Clinic all-round, 1996
N, SUWA, S, MORITA
openaire   +3 more sources